发布求助
文献互助 智能选刊 最新文献

Drugs of The Future最新文献

筛选
英文 中文
Zandelisib. Phosphatidylinositol 3-kinase delta (PI3Kdelta) inhibitor, Treatment of B-cell lymphomas Zandelisib。磷脂酰肌醇3-激酶δ (PI3Kdelta)抑制剂，治疗b细胞淋巴瘤
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2022-01-01 DOI: 10.1358/dof.2022.47.8.3427161
Q. Lu, Y. Xie, Z. Zhu, G. Huang, C. Ashby, Z. Chen
{"title":"Zandelisib. Phosphatidylinositol 3-kinase delta (PI3Kdelta) inhibitor, Treatment of B-cell lymphomas","authors":"Q. Lu, Y. Xie, Z. Zhu, G. Huang, C. Ashby, Z. Chen","doi":"10.1358/dof.2022.47.8.3427161","DOIUrl":"https://doi.org/10.1358/dof.2022.47.8.3427161","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66444958","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gene therapies for achromatopsia under clinical evaluation 基因治疗色盲的临床评价
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2022-01-01 DOI: 10.1358/dof.2022.47.7.3417139
E. A. Eton, C. Besirli
{"title":"Gene therapies for achromatopsia under clinical evaluation","authors":"E. A. Eton, C. Besirli","doi":"10.1358/dof.2022.47.7.3417139","DOIUrl":"https://doi.org/10.1358/dof.2022.47.7.3417139","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66444982","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Uproleselan sodium. E-selectin antagonist, Treatment of acute myeloid leukemia Uproleselan钠。e -选择素拮抗剂，治疗急性髓性白血病
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2022-01-01 DOI: 10.1358/dof.2022.47.8.3440034
P. Becker
{"title":"Uproleselan sodium. E-selectin antagonist, Treatment of acute myeloid leukemia","authors":"P. Becker","doi":"10.1358/dof.2022.47.8.3440034","DOIUrl":"https://doi.org/10.1358/dof.2022.47.8.3440034","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66445648","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
European Association for Cancer Research (EACR) - 28th Annual Meeting. Seville - June 20-23, 2022 欧洲癌症研究协会(EACR)第28届年会。塞维利亚——2022年6月20日至23日
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2022-01-01 DOI: 10.1358/dof.2022.47.9.3455363
C. Dulsat
{"title":"European Association for Cancer Research (EACR) - 28th Annual Meeting. Seville - June 20-23, 2022","authors":"C. Dulsat","doi":"10.1358/dof.2022.47.9.3455363","DOIUrl":"https://doi.org/10.1358/dof.2022.47.9.3455363","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66445665","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Furaprevir. HCV NS3/4A protease inhibitor, Treatment of chronic hepatitis C virus infection tract infection Furaprevir。HCV NS3/4A蛋白酶抑制剂治疗慢性丙型肝炎病毒感染道感染
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2022-01-01 DOI: 10.1358/dof.2022.47.8.3440035
P. Ghosh, V. Nehra, Z. Temesgen
{"title":"Furaprevir. HCV NS3/4A protease inhibitor, Treatment of chronic hepatitis C virus infection tract infection","authors":"P. Ghosh, V. Nehra, Z. Temesgen","doi":"10.1358/dof.2022.47.8.3440035","DOIUrl":"https://doi.org/10.1358/dof.2022.47.8.3440035","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66445698","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Therapeutic targets for paroxysmal nocturnal hemoglobinuria 阵发性夜间血红蛋白尿的治疗靶点
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2022-01-01 DOI: 10.1358/dof.2022.47.1.3393660
L. Sorbera, C. Dulsat, A. Graul
{"title":"Therapeutic targets for paroxysmal nocturnal hemoglobinuria","authors":"L. Sorbera, C. Dulsat, A. Graul","doi":"10.1358/dof.2022.47.1.3393660","DOIUrl":"https://doi.org/10.1358/dof.2022.47.1.3393660","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66440543","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pipeline on the Move - January 2022 管道在移动- 2022年1月
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2022-01-01 DOI: 10.1358/dof.2022.47.1.3397686
X. Bofill
{"title":"Pipeline on the Move - January 2022","authors":"X. Bofill","doi":"10.1358/dof.2022.47.1.3397686","DOIUrl":"https://doi.org/10.1358/dof.2022.47.1.3397686","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66440581","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Entospletinib. Spleen tyrosine kinase (SYK) inhibitor, Hematological cancer therapy Entospletinib。脾酪氨酸激酶(SYK)抑制剂，血液肿瘤治疗
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2022-01-01 DOI: 10.1358/dof.2022.47.2.3360406
Zhang Wei, J. Koya, Xingduo Dong, S. Reznik, Z. Chen
{"title":"Entospletinib. Spleen tyrosine kinase (SYK) inhibitor, Hematological cancer therapy","authors":"Zhang Wei, J. Koya, Xingduo Dong, S. Reznik, Z. Chen","doi":"10.1358/dof.2022.47.2.3360406","DOIUrl":"https://doi.org/10.1358/dof.2022.47.2.3360406","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66442358","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Avacincaptad pegol. Complement C5 inhibitor, Treatment of geographic atrophy secondary to dry age-related macular degeneration, Treatment of Stargardt disease Avacincaptad pegol。补体C5抑制剂，干性老年性黄斑变性继发地理性萎缩的治疗，Stargardt病的治疗
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2022-01-01 DOI: 10.1358/dof.2022.47.3.3378053
R. Hussain, L. Ciulla
{"title":"Avacincaptad pegol. Complement C5 inhibitor, Treatment of geographic atrophy secondary to dry age-related macular degeneration, Treatment of Stargardt disease","authors":"R. Hussain, L. Ciulla","doi":"10.1358/dof.2022.47.3.3378053","DOIUrl":"https://doi.org/10.1358/dof.2022.47.3.3378053","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66443255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
American Association for the Study of Liver Disease (AASLD) - The Liver Meeting. Virtual - November 12-15, 2021 美国肝病研究协会(AASLD)肝病会议。虚拟- 2021年11月12日至15日
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2022-01-01 DOI: 10.1358/dof.2022.47.3.3393249
J. Odland
{"title":"American Association for the Study of Liver Disease (AASLD) - The Liver Meeting. Virtual - November 12-15, 2021","authors":"J. Odland","doi":"10.1358/dof.2022.47.3.3393249","DOIUrl":"https://doi.org/10.1358/dof.2022.47.3.3393249","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66443475","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
首页 上一页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信